Skip to content
Monday, October 12, 2026
NewsUrbanBlog UK

Social Media Content Creators Fueling Parallel Trade for Unapproved Slimming Medication

An underground economy for unapproved slimming drugs is propelled by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its alleged weight-reducing properties. Followers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.

Thriving Trade on Social Networks

Additionally, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and chemists have warned that the sale of what remains an unapproved drug in the UK is worrisome and could result in users administering products of unknown origin.

Several experts stated the demand for retatrutide could be linked to the increasing cost of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators try to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, legal action or imprisonment.

Platform Reaction and Material Removal

According to TikTok, the platform has taken down violative content and prohibited related hashtags and search suggestions. The organization said it was dedicated to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Digital Trading Activities

Research also discovered communities with up to 9,000 participants selling retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up groups with numerous of members, populated with images of weight loss, positive reviews and step-by-step instructions for mixing or injecting at home.

Within minutes of joining one community, a seller shared WhatsApp details, where the majority of purchases occur. The vendor provided an guidebook and promised shipping within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Details and Costs

Within these communities, posts display dark colored parcels with Royal Mail labels, stating to contain new batches. One message stated: “It took eight of us to load them this morning.”

Buyers can select between powder vials, mixed at residence with purified liquid, or pre-filled injectors usually priced at £160 for 20mg. When questioned how long a injector should last, sellers give contradictory answers varying between a several days to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in interest to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her team has previously encountered patients injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may subject patients to potentially significant health risks”.

Written by

Angela Woods

Urban planner and journalist with over a decade of experience covering UK city development and policy changes.

NewsUrbanBlog UK

Type to search articles.